BioArctic revenue and financials
kr 302.20Change from previous close: +0.33%Absolute change: +kr 1.00
In the fiscal year ended December 2025, BioArctic reported revenue of kr 2B (+676.80% year over year). Net income was kr 1.02B, a net margin of 51.1%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +676.80%
- 2025 vs 2024
- Net margin
- 51.1%
- 2024: -68.8%
Financial data
Amounts in millions of SEK; per-share values in SEK; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Operating cash flow | 138 | -166 | 313 | -41.2 | 1,147 |
| Investing cash flow | -90.1 | 319 | -374 | 187 | -743 |
| Financing cash flow | -178 | 10.7 | 0.6 | 13.2 | 0.7 |
| Effect of exchange rates | 7.1 | 0.2 | -4.5 | -2.1 | -15.3 |
| Net change in cash | -130 | 164 | -59.6 | 159 | 405 |
| Free cash flow | 138 | -166 | 313 | -41.2 | 1,147 |